DEVELOPING · Attributed source report · science · World
Trial results posted: Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
NULLPEN · Source published 11/2/2026, 12:00:00 AM UTCClinicalTrials.gov records the first posting of results for study NCT04916470 on 2026-11-02. A registry posting does not establish that a treatment is effective or safe.
Why it matters
New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.
What remains uncertain
- The study findings have not been independently assessed by NULLPEN.